• Aucun résultat trouvé

Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: A French multicentre study

N/A
N/A
Info
Télécharger
Protected

Academic year: 2021

Partager "Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: A French multicentre study"

Copied!
15
0
0

Chargement.... (Voir le texte intégral maintenant)

Texte intégral

(1)

HAL Id: hal-01831902

https://hal.umontpellier.fr/hal-01831902

Submitted on 7 Apr 2020

HAL is a multi-disciplinary open access archive for the deposit and dissemination of sci- entific research documents, whether they are pub- lished or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.

L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.

Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension:

A French multicentre study

Sébastien Hascoet, Emmanuelle Fournier, Xavier Jaïs, Lauriane Le Gloan, Claire Dauphin, Ali Houeijeh, François Godart, Xavier Iriart, Adelaïde

Richard, Jelena Radojevic, et al.

To cite this version:

Sébastien Hascoet, Emmanuelle Fournier, Xavier Jaïs, Lauriane Le Gloan, Claire Dauphin, et al..

Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: A French multicentre study. Archives of cardiovascular diseases, Elsevier/French Society of Cardiology, 2017, 110 (5), pp.303-316. �10.1016/j.acvd.2017.01.006�. �hal-01831902�

(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)

Références

Télécharger maintenant ( PDF - 15 Page - 50.47 MB )

Documents relatifs

Pulmonary Arterial Hypertension:

The objective of this study is to investigate the ability and accuracy of OCT to detect and quantify intimal fibrosis, as a marker of histological remodeling of the pulmonary

Evaluation of Macitentan in Patients With Eisenmenger Syndrome:

The treatment effect expressed as the least-squares mean difference (macitentan minus placebo) for the change from baseline to week 16 in 6MWD was calculated by analysis of

Evaluation of Macitentan in Patients With Eisenmenger Syndrome:

China – Ethics Committee of Cardiovascular Institute and Fuwai Hospital for Clinical Trials, Beijing; Ethics Committee of Shanghai Pulmonary Hospital, Shanghai; Ethics Committee

A bosentan pharmacokinetic study to investigate dosing regimens in paediatric patients with pulmonary arterial hypertension: FUTURE-3

The aim of the present study was to investigate whether increasing the bosentan dosing frequency from 2 mg kg –1 twice daily (b.i.d.) to 2 mg kg –1 three times daily (t.i.d.)

François-Xavier de Zach

En octobre 1802, Frédéric-Guillaume de Prusse confia à notre Zach le relèvement astronomique et trigonométrique de la T h u - ringe, et le duc Ernest, toujours prêt à mettre

COLLEGE Mgr François Xavier VOGT - Yaoundé.

3· Réaliser l'étude dynamique sur chacune des poulies pour obtenir les relations entre les tensions et l'accélération angulaire des poulies, puis l'accélération des

Les Options Proposées au Lycée Saint François Xavier

En plus de l’enseignement de l’économie en langue anglaise les élèves bénéficient d'une heure supplémentaire en anglais, afin d'approfondir leurs connaissances et

Health-related quality of life of patients with pulmonary arterial hypertension associated with CHD: the multicentre cross-sectional ACHILLE study

17 The ACHILLE – Adults adolescents CHD with pulmonary arterial hypertension quality of life assessment – study aimed to evaluate health-related quality of life in a